InvestSMART

Holista Colltech Limited (ASX:HCT)

ALERT: Price-sensitive ASX Announcement for HCT
Current share price for HCT : $0.080 0.018 (29.03%)+
Announcement
Release
5 May 2026 8:16AM
Price at Release
$0.062
Full Release
download
Summary
Holista Colltech Limited announced a binding joint venture agreement with Swang Chai Chuan Limited for developing an ovine nano-collagen production facility in Collie, Western Australia. The joint venture will be managed under Ovicoll Pty Ltd with an initial ownership split of 50:50 between Holista and SCC. SCC will invest RM5,000,000 for initial funding, while Holista is granted an option to increase its ownership to 75% over the subsequent five years. Holista will oversee the day-to-day operations, with the board composed equally of Holista and SCC directors. Holista retains intellectual property rights, and the joint venture will pay Holista a royalty on sales. This venture is part of Holista's strategy to expand its collagen technology internationally through scalable production capabilities. SCC will assist in market development leveraging its network. The project represents a significant advancement in commercializing Holista's collagen technology, focusing on high-value products for various applications.
Key Points
  • Binding joint venture agreement with Swang Chai Chuan Limited.
  • Development of ovine nano-collagen facility in Collie, Western Australia.
  • Initial 50:50 ownership structure under Ovicoll Pty Ltd.
  • SCC to invest RM5,000,000 for initial funding; Holista can increase its stake to 75%.
  • Holista responsible for day-to-day operations.
  • Board of directors equally appointed by Holista and SCC.
  • Holista retains intellectual property rights.
  • JV to pay Holista a royalty on sales.
  • Significant step in commercializing collagen technology.
  • SCC to support market development activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.